Proton Pump Inhibitor Use Is Associated With Extended-Spectrum ß-Lactamase-Producing Enterobacteriaceae Rectal Carriage at Hospital Admission: A Cross-Sectional Study.
Clin Infect Dis
; 64(3): 361-363, 2017 Feb 01.
Article
em En
| MEDLINE
| ID: mdl-27965302
In this cross-sectional study, 8.5% of patients using proton pump inhibitors (PPIs) were rectal carriers of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-E), compared with 2.9% of non-PPI users. In multivariable analysis, PPI use was independently associated with ESBL-E rectal carriage at hospital admission (adjusted odds ratio, 3.89; 95% confidence interval, 1.65 - 9.19).
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Reto
/
Beta-Lactamases
/
Portador Sadio
/
Enterobacteriaceae
/
Infecções por Enterobacteriaceae
/
Inibidores da Bomba de Prótons
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limite:
Aged
/
Humans
/
Middle aged
País como assunto:
Europa
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article